文献速递自身免疫性与大疱性皮肤病

中国大疱性类天疱疮患者中免疫优势Th2细胞表位的鉴定

Identification of Immunodominant Th2-Cell Epitopes in Chinese Patients with Bullous Pemphigoid.
PubMed 文献 · J Invest Dermatol · 2018-03-26

该研究合成覆盖BP180-NC16A全序列的22条重叠肽,用ELISPOT检测大疱性类天疱疮患者Th2细胞对肽的反应性,筛选出P2(492-506 aa)和P5(501-515 aa)两条表位肽,并确认其主导刺激CD4+ T细胞增殖、Th2型IL-4产生及B细胞分泌自身抗体,且受HLA-DR限制。

要点

  • 合成22条覆盖BP180-NC16A全序列的重叠肽,用ELISPOT检测患者Th2细胞反应性。
  • 筛选出P2(492-506 aa)和P5(501-515 aa)两条免疫优势Th2细胞表位肽。
  • 两表位受HLA-DR限制,可刺激CD4+ T细胞增殖、IL-4产生及B细胞分泌自身抗体。

核心结论

  • 鉴定出P2和P5两条免疫优势Th2细胞表位,有助于阐明BP的表位介导免疫发病机制。
  • 所鉴定Th2细胞表位是表位特异性治疗策略的候选。

研究设计与样本

  • 研究合成22条覆盖BP180-NC16A全序列的重叠肽。
  • 采用酶联免疫斑点(ELISPOT)法检测大疱性类天疱疮患者Th2细胞对肽的反应性。

主要发现

  • 筛选出P2(492-506 aa:VRKLKARVDELERIR)和P5(501-515 aa:ELERIRRSILPYGDS)两条表位肽。
  • 两表位主导刺激CD4+ T细胞增殖和Th2型IL-4细胞因子产生。
  • 两表位可激活B细胞分泌自身抗体。
  • 两免疫优势表位受HLA-DR限制,且在不同HLA等位基因的受试者中均观察到。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease caused by autoantibodies targeting the juxtamembranous extracellular noncollagenous 16A (NC16A) domain of human collagen XVII (also known as BP180). Because T-helper (Th) cells are essential for antibody responses to antigens, we adopted an assay to map the immunodominant Th2-cell epitopes in NC16A. We synthesized 22 overlapping peptides spanning the entire sequence of BP180-NC16A and investigated the reactivity of Th2 cells from patients with BP to these peptides using the Enzyme-Linked ImmunoSpot (ELISPOT) assay. We screened two epitope peptides, P2 (492-506 aa: VRKLKARVDELERIR) and P5 (501-515 aa: ELERIRRSILPYGDS), and confirmed that these epitopes play a dominant role in stimulating CD4+ T-cell proliferation and Th2 IL-4 cytokine production, and activating B cells to secrete autoantibodies. These immunodominant epitopes are HLA-DR-restricted and were observed in subjects with different HLA alleles. This work contributes to elucidation of the epitope-mediated immunologic pathogenesis of BP, and the identified Th2-cell epitopes are candidates for epitope-specific therapeutic strategy.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Zhang J, Fang H, Shen S, et al. Identification of Immunodominant Th2-Cell Epitopes in Chinese Patients with Bullous Pemphigoid. J Invest Dermatol. 2018. PMID: 29588155. doi:10.1016/j.jid.2018.03.1515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。